Go Pro

LENZ Therapeutics (LENZ) Institutional Ownership

LENZ Therapeutics logo
$3.53 -0.26 (-6.75%)
As of 03:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for LENZ Therapeutics (NASDAQ:LENZ)

Current
Institutional Ownership
Percentage
54.32%
Number of
Institutional Buyers
(last 12 months)
121
Total
Institutional Inflows
(last 12 months)
$427.99M
Number of
Institutional Sellers
(last 12 months)
22
Total
Institutional Outflows
(last 12 months)
$55.40M
Get LENZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling LENZ Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LENZ Institutional Buying and Selling by Quarter

LENZ Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Squarepoint Ops LLC1,747,096$9.92M0.0%+16.0%5.560%
8/27/2026Corient Private Wealth LP74,931$426K0.0%+101.1%0.238%
8/21/2026AXQ Capital LP12,744$72K0.0%-76.6%0.041%
8/20/2026Susquehanna Fundamental Investments LLC17,900$102K0.0%N/A0.057%
8/20/2026Alyeska Investment Group L.P.438,882$2.49M0.0%-5.3%1.397%
8/19/2026Hsbc Holdings PLC79,811$449K0.0%+264.5%0.254%
8/18/2026Jefferies Financial Group Inc.200,300$1.14M0.0%N/A0.637%
8/17/2026Corient Private Wealth LP74,730$424K0.0%N/A0.238%
8/17/2026Bank of America Corp DE255,410$1.45M0.0%N/A0.813%
8/14/2026Hsbc Holdings PLC79,811$449K0.0%N/A0.254%
8/14/2026Primecap Management Co. CA472,200$2.68M0.0%N/A1.503%
8/13/2026Connor Clark & Lunn Investment Management Ltd.33,257$189K0.0%N/A0.106%
8/12/2026Ieq Capital LLC29,692$169K0.0%N/A0.095%
8/11/2026Blue Owl Capital Holdings LP756,722$4.30M0.6%N/A2.414%
8/7/2026BlackRock Inc.2,292,121$13.02M0.0%N/A7.311%
8/7/2026Deutsche Bank AG16,290$93K0.0%N/A0.052%
8/6/2026Bank of New York Mellon Corp56,016$318K0.0%N/A0.179%
5/19/2026Bank of America Corp DE547,534$5.01M0.0%+377.4%1.746%
5/18/2026Royal Bank of Canada95,235$870K0.0%+120.6%0.304%
5/16/2026Quantinno Capital Management LP47,648$436K0.0%N/A0.152%
5/15/2026Affinity Asset Advisors LLC100,000$915K0.0%-200.0%0.319%
5/14/2026Knott David M Jr33,732$309K0.2%-37.2%0.108%
5/7/2026Dimensional Fund Advisors LP41,874$381K0.0%-63.0%0.134%
5/7/2026KBC Group NV90,425$827K0.0%N/A0.288%
5/6/2026C WorldWide Group Holding A S700,000$6.41M0.1%+40.0%2.233%
5/5/2026Bank of New York Mellon Corp49,797$456K0.0%+13.0%0.159%
4/30/2026Hsbc Holdings PLC21,894$204K0.0%N/A0.070%
4/27/2026Y Intercept Hong Kong Ltd158,715$1.45M0.0%+290.8%0.506%
4/22/2026Janney Montgomery Scott LLC10,814$99K0.0%N/A0.034%
3/17/2026Rockefeller Capital Management L.P.48,071$769K0.0%+167.1%0.154%
3/3/2026Caitong International Asset Management Co. Ltd3,686$59K0.0%N/A0.012%
2/26/2026Aristides Capital LLC10,500$168K0.0%N/A0.034%
2/23/2026Virtu Financial LLC12,347$198K0.0%N/A0.039%
2/19/2026Invesco Ltd.14,046$225K0.0%-96.1%0.045%
2/18/2026XTX Topco Ltd85,782$1.37M0.0%N/A0.274%
2/18/2026VARCOV Co.78,831$1.26M0.5%N/A0.252%
2/18/2026Vestal Point Capital LP275,000$4.40M0.1%N/A0.879%
2/18/2026Virtus Investment Advisers LLC37,674$603K0.2%+879.3%0.120%
2/18/2026Wellington Management Group LLP54,402$870K0.0%-11.3%0.174%
2/18/2026Tang Capital Management LLC865,169$13.84M0.7%-3.6%2.765%
Trump goes "all-in" on Grand Canyon energy breakthrough (Ad)

A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery.tc pixel

See the ticker behind this Grand Canyon energy breakthrough now
2/18/2026Perceptive Advisors LLC50,000$800K0.0%N/A0.160%
2/18/2026Millennium Management LLC539,348$8.63M0.0%N/A1.724%
2/18/2026Engineers Gate Manager LP31,058$497K0.0%N/A0.099%
2/17/2026Freestone Grove Partners LP22,971$368K0.0%N/A0.073%
2/17/2026Trexquant Investment LP173,183$2.77M0.0%N/A0.553%
2/17/2026Jump Financial LLC40,851$654K0.0%N/A0.131%
2/17/2026Price T Rowe Associates Inc. MD1,023,542$16.38M0.0%+307.6%3.271%
2/17/2026Rock Springs Capital Management LP257,460$4.12M0.2%+9.0%0.823%
2/17/2026Russell Investments Group Ltd.15,461$247K0.0%-89.3%0.049%
2/17/2026Granahan Investment Management LLC431,100$6.90M0.3%+125.2%1.378%
2/17/2026State of Wisconsin Investment Board32,235$516K0.0%+33.7%0.103%
2/17/2026ExodusPoint Capital Management LP23,147$370K0.0%N/A0.074%
2/17/2026Royal Bank of Canada43,172$691K0.0%-10.6%0.138%
2/17/2026Blair William & Co. IL10,207$163K0.0%+27.7%0.033%
2/16/2026Squarepoint Ops LLC491,898$7.87M0.0%+447.8%1.572%
2/16/2026Verition Fund Management LLC46,268$740K0.0%N/A0.148%
2/16/2026Entropy Technologies LP11,000$176K0.0%N/A0.035%
2/16/2026Barclays PLC72,432$1.16M0.0%+51.4%0.231%
2/13/2026Marshall Wace LLP35,252$564K0.0%N/A0.113%
2/13/2026AWM Investment Company Inc.150,000$2.40M0.2%N/A0.479%
2/13/2026Jacobs Levy Equity Management Inc.270,919$4.34M0.0%N/A0.866%
2/13/2026Vivaldi Capital Management LP64,052$1.03M0.1%+23.8%0.205%
2/13/2026Alyeska Investment Group L.P.463,495$7.42M0.0%+91.4%1.481%
2/13/2026Charles Schwab Investment Management Inc.169,122$2.71M0.0%+5.4%0.540%
2/13/2026State Street Corp510,749$8.17M0.0%+22.2%1.632%
2/13/2026Caitong International Asset Management Co. Ltd1,988$32K0.1%N/A0.006%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC18,851$302K0.0%+61.2%0.060%
2/13/2026Wells Fargo & Company MN22,916$367K0.0%+119.3%0.073%
2/12/2026HRT Financial LP171,283$2.74M0.0%+484.4%0.547%
2/12/2026Aristides Capital LLC10,500$168K0.0%N/A0.034%
2/12/2026Dimensional Fund Advisors LP113,094$1.81M0.0%+176.6%0.361%
2/12/2026Federated Hermes Inc.62,636$1.00M0.0%N/A0.200%
2/12/2026Marex Group plc16,000$256K0.0%N/A0.051%
2/12/2026New York State Common Retirement Fund6,693$107K0.0%+49.0%0.021%
2/12/2026Knott David M Jr53,732$860K0.4%-34.5%0.172%
2/12/2026Nuveen LLC39,905$638K0.0%-86.0%0.128%
2/11/2026Primecap Management Co. CA372,200$5.96M0.0%N/A1.190%
2/11/2026Fox Run Management L.L.C.15,739$252K0.0%N/A0.050%
2/11/2026Franklin Resources Inc.1,096,334$17.54M0.0%+86.7%3.504%
2/11/2026Los Angeles Capital Management LLC3,888$62K0.0%N/A0.012%
2/11/2026Propel Bio Management LLC59,085$945K0.8%N/A0.189%
2/11/2026State of Wyoming1,849$30K0.0%N/A0.006%
2/10/2026TD Asset Management Inc26,978$432K0.0%-14.1%0.086%
2/10/2026Goldman Sachs Group Inc.257,942$4.13M0.0%+524.9%0.824%
2/10/2026AXQ Capital LP19,839$317K0.1%+289.2%0.063%
2/10/2026Nomura Asset Management Co. Ltd.96,780$1.55M0.0%+121.1%0.309%
2/9/2026Geode Capital Management LLC461,075$7.38M0.0%+1.4%1.474%
2/9/2026Sectoral Asset Management Inc.42,500$680K0.5%N/A0.136%
2/9/2026Blue Owl Capital Holdings LP150,000$2.40M0.2%N/A0.479%
2/9/2026Simplify Asset Management Inc.17,481$280K0.0%N/A0.056%
How Elon’s Empire Ends (and how to profit) (Ad)

Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg terminal, says a new micro cluster AI technology could render today's data centers, including Elon Musk's Colossus in Tennessee, obsolete for major breakthroughs. These next generation centers use 99 percent less space, electricity and water, yet Chaikin's research shows they could be more than a trillion times more powerful than the top data center on earth today, potentially cutting AI breakthrough timelines from five years to five days.tc pixel

See Chaikin's full research and the company name here
2/5/2026AlphaCore Capital LLC10,000$160K0.0%N/A0.032%
2/5/2026DNB Asset Management AS19,163$307K0.0%N/A0.061%
2/4/2026C WorldWide Group Holding A S500,000$8M0.1%N/A1.598%
1/29/2026UBS Group AG1,571,738$25.15M0.0%+30.8%5.023%
1/29/2026China Universal Asset Management Co. Ltd.5,099$82K0.0%-36.3%0.016%
1/23/2026State of Alaska Department of Revenue19,159$306K0.0%N/A0.061%
1/20/2026Sovran Advisors LLC160,134$2.56M0.2%+49.8%0.512%
1/20/2026Harbor Capital Advisors Inc.23,921$383K0.0%+63.8%0.076%
1/16/2026Aberdeen Group plc489,432$7.83M0.0%+274.4%1.564%
1/1/2026JPMorgan Chase & Co.11,222$523K0.0%+8.3%0.036%


LENZ Institutional Ownership - Frequently Asked Questions

During the previous two years, 163 institutional investors and hedge funds held shares of LENZ Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($123.76M), Vanguard Group Inc. ($61.97M), Paradigm Biocapital Advisors LP ($50.00M), Adage Capital Partners GP L.L.C. ($32.91M), First Light Asset Management LLC ($32.28M), Samsara BioCapital LLC ($28.49M), and UBS Group AG ($25.15M).Learn more on LENZ Therapeutics' institutional investors.

54.32% of LENZ Therapeutics' stock is owned by institutional investors. Learn more on LENZ's institutional investor holdings.

Of the 153 institutional investors that purchased LENZ Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($2.66M), BlackRock Inc. ($2.29M), Paradigm Biocapital Advisors LP ($1.51M), Price T Rowe Associates Inc. MD ($1.15M), Adage Capital Partners GP L.L.C. ($1.12M), Franklin Resources Inc. ($1.09M), and Bank of America Corp DE ($1.04M).

Institutional investors have bought a total of 18,696,633 shares in the last 24 months. This purchase volume represents approximately $427.99M in transactions.

Of the 22 institutional investors that sold LENZ Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Paradigm Biocapital Advisors LP ($643.61K), Invesco Ltd. ($350.22K), Nuveen LLC ($245.64K), Ally Bridge Group NY LLC ($167.96K), Russell Investments Group Ltd. ($129.05K), Dimensional Fund Advisors LP ($71.22K), and Knott David M Jr ($48.27K).

Institutional investors have sold a total of 1,849,489 shares in the last 24 months. This volume of shares sold represents approximately $55.40M in transactions.



Institutional ownership data for NASDAQ:LENZ is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners